BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18310074)

  • 1. IPP5, a novel protein inhibitor of protein phosphatase 1, promotes G1/S progression in a Thr-40-dependent manner.
    Wang X; Liu B; Li N; Li H; Qiu J; Zhang Y; Cao X
    J Biol Chem; 2008 May; 283(18):12076-84. PubMed ID: 18310074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IPP5, a novel inhibitor of protein phosphatase 1, suppresses tumor growth and progression of cervical carcinoma cells by inducing G2/M arrest.
    Zeng Q; Huang Y; Zeng L; Huang Y; Cai D; Zhang H
    Cancer Genet; 2012 Sep; 205(9):442-52. PubMed ID: 22939397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of IPP5, a novel inhibitor of PP1, on apoptosis and the underlying mechanisms involved.
    Zeng Q; Huang Y; Zeng L; Lan X; Huang Y; He S; Zhang H
    Biotechnol Appl Biochem; 2009 Dec; 54(4):231-8. PubMed ID: 19874272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IPP5 inhibits neurite growth in primary sensory neurons by maintaining TGF-β/Smad signaling.
    Han QJ; Gao NN; Guo-QiangMa ; Zhang ZN; Yu WH; Pan J; Wang Q; Zhang X; Bao L
    J Cell Sci; 2013 Jan; 126(Pt 2):542-53. PubMed ID: 23203807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutively active protein phosphatase 1alpha causes Rb-dependent G1 arrest in human cancer cells.
    Berndt N; Dohadwala M; Liu CW
    Curr Biol; 1997 Jun; 7(6):375-86. PubMed ID: 9197238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8-60hIPP5(m)-induced G2/M cell cycle arrest involves activation of ATM/p53/p21(cip1/waf1) pathways and delayed cyclin B1 nuclear translocation.
    Zeng QY; Zeng LJ; Huang Y; Huang YQ; Zhu QF; Liao ZH
    Asian Pac J Cancer Prev; 2014; 15(9):4101-7. PubMed ID: 24935604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of protein phosphatase-1 and -2A decreases the chemosensitivity of leukemic cells to chemotherapeutic drugs.
    Dedinszki D; Kiss A; Márkász L; Márton A; Tóth E; Székely L; Erdődi F
    Cell Signal; 2015 Feb; 27(2):363-72. PubMed ID: 25435424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
    Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
    Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2.
    Lents NH; Keenan SM; Bellone C; Baldassare JJ
    J Biol Chem; 2002 Dec; 277(49):47469-75. PubMed ID: 12359725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphatase PP6 N terminal domain restricts G1 to S phase progression in human cancer cells.
    Stefansson B; Brautigan DL
    Cell Cycle; 2007 Jun; 6(11):1386-92. PubMed ID: 17568194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the retinoblastoma protein and protein phosphatase 1 during the cell cycle.
    Berndt N; Ludlow JW
    Methods Mol Biol; 2004; 281():17-32. PubMed ID: 15220519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel phosphorylation-dependent regulation in an unstructured protein.
    Cannon JF
    Proteins; 2020 Feb; 88(2):366-384. PubMed ID: 31512287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKA.
    Liu QR; Zhang PW; Lin Z; Li QF; Woods AS; Troncoso J; Uhl GR
    Biochem J; 2004 Jan; 377(Pt 1):171-81. PubMed ID: 12974676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells.
    Xu W; Yuan X; Jung YJ; Yang Y; Basso A; Rosen N; Chung EJ; Trepel J; Neckers L
    Cancer Res; 2003 Nov; 63(22):7777-84. PubMed ID: 14633703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein phosphatase 1 dephosphorylates Orc2.
    Lee KY; Bae JS; Kim GS; Hwang DS
    Biochem Biophys Res Commun; 2014 May; 447(3):437-40. PubMed ID: 24732362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phosphatase inhibitor okadaic acid stimulates the TSH-induced G1-S phase transition in thyroid cells.
    Lazzereschi D; Coppa A; Minicione G; Lavitrano M; Fragomele F; Colletta G
    Exp Cell Res; 1997 Aug; 234(2):425-33. PubMed ID: 9260913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclin D1 overexpression on G1 progression-related events.
    Imoto M; Doki Y; Jiang W; Han EK; Weinstein IB
    Exp Cell Res; 1997 Oct; 236(1):173-80. PubMed ID: 9344597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis.
    Flores-Delgado G; Liu CW; Sposto R; Berndt N
    J Proteome Res; 2007 Mar; 6(3):1165-75. PubMed ID: 17274640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells.
    Verdugo-Sivianes EM; Rojas AM; Muñoz-Galván S; Otero-Albiol D; Carnero A
    Theranostics; 2021; 11(7):3452-3471. PubMed ID: 33537097
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1.
    Connor JH; Weiser DC; Li S; Hallenbeck JM; Shenolikar S
    Mol Cell Biol; 2001 Oct; 21(20):6841-50. PubMed ID: 11564868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.